Nifenazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H16N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8780F0K71U, chemically known as 2,3-dimethyl-4-nicotinamido-1-phenyl-3-pyrazolin-5-on but generally known as nifenazone, which bears US NIH Compound Identifier 4487. European Medicines Agency schedules Nifenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09256MIG. The term NIFENAZONE is an International Non-Proprietary Name. World Health Organization schedules nifenazone in its Anatomical Therapeutic Chemical (ATC) Classification. NIFENAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nifenazone under HS 29333999 and SITC 51574. As of Q4 2014, NIFENAZONE remains the US FDA Preferred Term for this commodity. Nifenazone bears US NLM identifiers UMLS ID C0068738 and NCI Concept Code C76806. SMILES: O=C1N(N(C(C1NC(=O)C1CCCNC1)C)C)C1CCCCC1.